Mechanistic Analysis of Drug Release from Theophylline Pellets Coated by Films Containing Pectin, Chitosan and Eudragit® RS
Authors:
- Mohammad Reza AvadiMAMohammad Reza Avadi
- Hamid Reza MoghimiHMHamid Reza Moghimi
- Mahvash OskouiMOMahvash Oskoui
- Khosrow BayatiKBKhosrow Bayati
- Morteza Rafiee-TehraniMRMorteza Rafiee-Tehrani
- 1 January 2008
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 34 (4) , 390-402
Abstract
The objective of this study was to obtain detailed information on the mechanism of drug release from mixed-film of pectin-chitosan/Eudragit RS. Pellets (710-840 microm in diameter) containing 60% theophylline and 40% microcrystalline cellulose were prepared by extrusion-spheronization method. Eudragit L100-55 enteric coating capsules included film-coated pellets of theophylline in theoretical coating weight gains of 10, 15, and 20%, with pectin-chitosan complex contents of 5, 10, 15, and 20% for each level of weight gain were prepared and subjected to in vitro drug release. Drug release from this system showed a bimodal release profile characteristic with the drug release enhancement, being triggered (burst release) in the colonic medium. The reason for burst drug release may be due to the enzymatic degradation of pectin via pectinolytic enzymes in the simulated colonic medium. The mechanism of drug release from each formulation was evaluated in the terms of zero-order, first-order, Higuchi and Korsmeyer-Peppas models. It was observed that none of the enteric coating capsules showed any drug release in the simulated gastric medium (phase I). The analysis of release profiles showed that zero-order kinetics was found as the better fitting model for all formulations in the simulated small intestine (phase II) and it could be due to the pectin-chitosan swelling and subsequent formation of aqueous channels. In the colonic medium (phase III), due to degradation of pectin and its leaching from the mixed-film, there was a modification in drug release kinetics from swelling-controlled at phase II to anomalous at phase III. It also was found that both zero-order and Higuchi models contributed in colonic drug release from most of the formulations.Keywords
This publication has 47 references indexed in Scilit:
- Microbial pectinolytic enzymes: A reviewProcess Biochemistry, 2005
- Studies on the physical properties of mixed pectin/ethylcellulose films intended for colonic drug deliveryInternational Journal of Pharmaceutics, 1997
- Calcium pectinate gel coated pellets as an alternative carrier to calcium pectinate beadsInternational Journal of Pharmaceutics, 1997
- Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug releaseJournal of Controlled Release, 1997
- Optima: A Windows-Based Program for Computer-Aided Optimization of Controlled-Release Dosage FormsPharmaceutical Development and Technology, 1996
- Cellulose Matrices for Zero-Order Release of Soluble DrugsDrug Development and Industrial Pharmacy, 1988
- A simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJournal of Controlled Release, 1987
- A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discsJournal of Controlled Release, 1987
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963
- Rate of Release of Medicaments from Ointment Bases Containing Drugs in SuspensionJournal of Pharmaceutical Sciences, 1961